For long-term wealth builders, turning an initial $20,000 into $200,000 means achieving a 10-fold return. While that may seem out of reach in the short term, over a 20-year horizon, it is mathematically entirely feasible at a compound annual growth rate of approximately 12.2%.
On the Toronto Stock Exchange, two small- to mid-cap growth companies with clear business models and long-term expansion potential in their respective sectors — Docebo (TSX:DCBO) and WELL Health Technologies (TSX:WELL) — are worth investors’ attention.
Docebo: An AI-Powered Enterprise Learning Platform
Docebo provides a cloud-based training and learning platform for large organizations to train employees, customers, and partners across onboarding, compliance, and professional skills development. Once deeply embedded in daily operations, this business model generates recurring subscription revenue.
Artificial intelligence is becoming a key variable in enhancing Docebo’s platform value. In January 2026, the company acquired 365Talents, an AI-driven skills intelligence and workforce analytics firm, gaining technology to identify employee skills, uncover capability gaps, and proactively recommend training or internal mobility opportunities — tightly binding skills management with learning execution. Financially, Docebo reported first-quarter annual recurring revenue (ARR) of US$248.9 million, up 10.6% year-over-year, while free cash flow climbed to US$27.6 million, demonstrating its ability to improve profitability through operational efficiency even as it expands.
Despite recent valuation adjustments in the software sector, Docebo’s market capitalization of roughly US$650 million (approximately US$480 million) leaves considerable room for growth if its AI-powered platform continues to win large enterprise customers.
WELL Health: A Hybrid of Physical Clinics and Digital Healthcare
WELL Health is a unique player in Canada’s digital health space, operating a dual business model that combines “physical” and “digital” — running a network of brick-and-mortar medical clinics while supplying digital tools that help healthcare providers manage patients, electronic records, billing, cybersecurity, and virtual care.
This combination allows WELL Health to benefit simultaneously from direct healthcare delivery and back-end system efficiency gains. Against the structural challenges of Canada’s physician shortages, aging population, and overburdened healthcare system, demand for WELL Health’s services remains robust. In the first quarter of 2026, the company recorded 1.9 million patient visits, while revenue rose 25% year-over-year to C$368.3 million. More notably, its Canadian operations (including clinics and the WellStar software platform) achieved a C$100 million annualized adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) run rate three quarters ahead of schedule — and on lower revenue than originally projected — proving that operational efficiency is improving as the business scales.
With WELL Health’s current market capitalization at approximately C$1.1 billion, if management continues to deliver on growth and efficiency improvements over the next several years, the long-term return potential is worth watching.
Risks and Investment Strategy
Of course, these investments are not without risks. Docebo faces intense software competition, lengthy enterprise sales cycles, and integration uncertainties from acquisitions. WELL Health carries debt, relies in part on acquisitions for growth, and operates within highly regulated healthcare systems. Both stocks are highly volatile, and sharp price corrections can occur even when the long-term thesis remains intact.
Investors may consider a gradual position-building approach, spreading capital across both companies while maintaining patience measured in years. Docebo offers recurring software revenue tied to AI and workforce development, while WELL Health combines digital healthcare with a rapidly expanding clinic network. A $10,000 allocation to each does not guarantee a 10-fold return, but the market capitalizations of both companies — and the vast size of the markets they address — make that long-term goal worthy of serious consideration.
